DATA GRAPHICS | Data Byte
Handful of biotechs squeeze through IPO window in 2Q22
Five biotech companies priced IPOs in 2Q22, led by HilleVax
July 6, 2022 9:42 PM UTC
Only five biotech companies priced IPOs in 2Q22, raising $482.9 million, according to BioCentury’s BCIQ database. HilleVax Inc. (NASDAQ:HLVX) raised the most among the quintet at $230 million, but its shares have been the hardest hit, down 32% since their debut...